Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXPLORATORY STUDY OF PLAQUE REGRESSION:A Phase II Single Center Open-Label Exploratory Trial of the Effect of CER 001 in Subjects With Familial Hypercholesterolemia

NCT01515241 is registered in ClinicalTrials.gov with Cerenis Therapeutics, SA as lead sponsor.

NCT NCT01515241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01515241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXPLORATORY STUDY OF PLAQUE REGRESSION:A Phase II Single Center Open-Label Exploratory Trial of the Effect of CER 001 in Subjects With Familial Hypercholesterolemia
Lead sponsor
Cerenis Therapeutics, SA
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
May 31, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heterozygous familial hypercholesterolemia